Ammonia Solution, Strong

Ammonia Solution, Strong

SCHEMBL197247

CCCCNC(CC)CC.N

nearest known ligand 0.46

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.46
CNR1 P21554 1/20 0.46
ADRA1A P35348 1/20 0.46
TDP1 Q9NUW8 1/20 0.46
KDM4E B2RXH2 1/20 0.46
ABCC3 O15438 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
TSHR P16473 4/20 0.39
ALDH1A1 P00352 3/20 0.35
CA1 P00915 2/20 0.35
CA2 P00918 2/20 0.35
ADH1B P00325 1/20 0.35
ADH1C P00326 1/20 0.35
ADH1A P07327 1/20 0.35
ADH7 P40394 1/20 0.35
CA12 O43570 1/20 0.35
CA7 P43166 1/20 0.35
CA14 Q9ULX7 1/20 0.35
POLB P06746 1/20 0.33
MAPT P10636 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5367349 0.97 LMNA (0.48) LMNACNR1ADRA1ATDP1KDM4E
Hydrochloric Acid SCHEMBL22575418 0.94 ABCC3 (0.50) LMNACNR1ADRA1ATDP1KDM4E
Hydrazine SCHEMBL28481730 0.92 LMNA (0.44) LMNACNR1ADRA1ATDP1KDM4E
Ammonia Solution, Strong SCHEMBL198005 0.90 EPHX1 (0.46) LMNACNR1ADRA1ATDP1KDM4E
Ammonia Solution, Strong SCHEMBL197373 0.90 EPHX1 (0.46) LMNACNR1ADRA1ATDP1KDM4E
SCHEMBL7775237 0.89 TSHR (0.48) LMNACNR1ADRA1ATDP1KDM4E
SCHEMBL25132260 0.86 EPHX1 (0.48) LMNACNR1ADRA1ATDP1KDM4E
SCHEMBL7776968 0.86 EPHX1 (0.48) LMNACNR1ADRA1ATDP1KDM4E
Hydrochloric Acid SCHEMBL22575318 0.86 ABCC3 (0.48) LMNACNR1ADRA1ATDP1KDM4E
SCHEMBL20033727 0.86 EPHX1 (0.48) LMNACNR1ADRA1ATDP1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 75 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118480173-A Cationic polyester and preparation method and application thereof 深圳市信必递生物科技有限公司 2024-08-13 CN disclosed
EP-3642253-B1 BLOCKING AGENTS FOR AMINES, LATENT CURING AGENTS AND POLYURETHANE COMPOSITIONS SIKA TECH AG (CH) 2023-05-10 EP disclosed
US-11518736-B2 Blocking agent for amines, latent hardeners and polyurethane compositions SIKA TECHNOLOGY AG (CH) 2022-12-06 US disclosed
CN-115368824-A Fast curing migration-free compositions based on organic polymers containing silane groups SIKA技术股份公司 2022-11-22 CN disclosed
EP-3394132-B1 TWO-COMPONENT POLYURETHANE COMPOSITION SIKA TECH AG (CH) 2022-11-09 EP disclosed
EP-3394139-B1 POLYURETHANE COMPOSITION WITH LOW PLASTICIZER MIGRATION SIKA TECH AG (CH) 2022-07-20 EP disclosed
US-20220144746-A1 PROCESS FOR PRODUCING 2,2-DIALKYL-3-ACYLOXYPROPANALS SIKA TECHNOLOGY AG (CH) 2022-05-12 US disclosed
CN-110753711-B Amine blocking agent, latent curing agent and polyurethane composition SIKA技术股份公司 2022-04-05 CN disclosed
EP-3969435-A1 PROCESS FOR PRODUCING 2,2-DIALKYL-3-ACYLOXYPROPANALS Sika Technology AG (CH) 2022-03-23 EP disclosed
CN-108368233-B Two-component polyurethane composition SIKA技术股份公司 2022-02-08 CN disclosed
US-20100130674-A1 METHOD FOR THE PRODUCTION OF POLYURETHANE COMPOSITIONS WITH A LOW ISOCYANATE MONOMER CONTENT SIKA TECHNOLOGY AG (CH) 2010-05-27 US disclosed
US-20100101455-A1 ALDIMINES AND COMPOSITIONS COMPRISING ALDIMINE SIKA TECHNOLOGY AG (CH) 2010-04-29 US disclosed
US-20100006221-A1 Amorphous polyurethane polymer and its use in hotmelt adhesives SIKA TECHNOLOGY AG (CH) 2010-01-14 US disclosed
US-20100003526-A1 Polyurethane composition with good initial strength SIKA TECHNOLOGY AG (CH) 2010-01-07 US disclosed
US-7629433-B2 Odor-less during hydrolytic deblocking, separation; for use as source for aldehydes; crosslinking agents SIKA TECHNOLOGY AG (CH) 2009-12-08 US disclosed
US-20090176944-A1 Aldimines Comprising Reactive Groups Containing Active Hydrogen, and Use Thereof SIKA TECHNOLOGY AG (CH) 2009-07-09 US disclosed
US-20090159204-A1 Moisture-Hardened Polyurethane Compositions Containing Compounds Comprising Aldimine SIKA TECHNOLOGY AG 2009-06-25 US disclosed
US-20090099333-A1 Compounds Containing Aldimine SIKA TECHNOLOGY AG (CH) 2009-04-16 US disclosed
US-20080280145-A1 moisture-reactive hot-melt adhesive which comprises at least one aldimine and at least one polyurethane polymer ( polyesterurethane copolymer, polyetherurethane copolymer)which contains isocyanate groups and is solid at room temperature; bonded assembly is notable for improved adhesive SIKA TECHNOLOGY AG (CH) 2008-11-13 US disclosed
US-20080251204-A1 Reactive Polyurethane-Hot Melt Adhesive Having a Low Isocyanate-Monomer Content SIKA TECHNOLOGY AG (CH) 2008-10-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11518736-B2 Blocking agent for amines, latent hardeners and polyurethane compositions ODC1, KDM2B, ALKBH2 LMNA 1024/4885CNR1 2867/4885ADRA1A 850/4885
US-20100101455-A1 ALDIMINES AND COMPOSITIONS COMPRISING ALDIMINE ALDH7A1, ILK, ALDH3A1 LMNA 404/4885CNR1 4806/4885ADRA1A 2896/4885
US-20090176944-A1 Aldimines Comprising Reactive Groups Containing Active Hydrogen, and Use Thereof ADH5, ADH1C, ADH1A LMNA 2995/4885CNR1 3485/4885ADRA1A 562/4885
US-20220144746-A1 PROCESS FOR PRODUCING 2,2-DIALKYL-3-ACYLOXYPROPANALS ADCY4, ADCY1, ADCY2 LMNA 1370/4885CNR1 2378/4885ADRA1A 294/4885
US-20090099333-A1 Compounds Containing Aldimine ALDH7A1, ALDH3A1, ALDH1A1 LMNA 2415/4885CNR1 2903/4885ADRA1A 1771/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.